ConclusionsVitamin E was superior to placebo for the treatment of nonalcoholic steatohepatitis in adults without diabetes.There was no benefit of pioglitazone over placebo for the primary outcome; however, significant benefits of pioglitazone were observed for some of the secondary outcomes.(ClinicalTrials.govnumber, NCT00063622.)
No takes yet. Share an insight, caveat, or question.
A 2010 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: